Literature DB >> 18556784

Characterization of lipooligosaccharide-biosynthetic loci of Campylobacter jejuni reveals new lipooligosaccharide classes: evidence of mosaic organizations.

Craig T Parker1, Michel Gilbert, Nobuhiro Yuki, Hubert P Endtz, Robert E Mandrell.   

Abstract

The lipooligosaccharide (LOS) biosynthesis region is one of the more variable genomic regions between strains of Campylobacter jejuni. Indeed, eight classes of LOS biosynthesis loci have been established previously based on gene content and organization. In this study, we characterize additional classes of LOS biosynthesis loci and analyze various mechanisms that result in changes to LOS structures. To gain further insights into the genomic diversity of C. jejuni LOS biosynthesis region, we sequenced the LOS biosynthesis loci of 15 strains that possessed gene content that was distinct from the eight classes. This analysis identified 11 new classes of LOS loci that exhibited examples of deletions and insertions of genes and cassettes of genes found in other LOS classes or capsular biosynthesis loci leading to mosaic LOS loci. The sequence analysis also revealed both missense mutations leading to "allelic" glycosyltransferases and phase-variable and non-phase-variable gene inactivation by the deletion or insertion of bases. Specifically, we demonstrated that gene inactivation is an important mechanism for altering the LOS structures of strains possessing the same class of LOS biosynthesis locus. Together, these observations suggest that LOS biosynthesis region is a hotspot for genetic exchange and variability, often leading to changes in the LOS produced.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18556784      PMCID: PMC2519380          DOI: 10.1128/JB.00254-08

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  34 in total

Review 1.  Improving the accuracy of PSI-BLAST protein database searches with composition-based statistics and other refinements.

Authors:  A A Schäffer; L Aravind; T L Madden; S Shavirin; J L Spouge; Y I Wolf; E V Koonin; S F Altschul
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

2.  Comparative genome analysis of Campylobacter jejuni using whole genome DNA microarrays.

Authors:  B M Pearson; C Pin; J Wright; K I'Anson; T Humphrey; J M Wells
Journal:  FEBS Lett       Date:  2003-11-06       Impact factor: 4.124

3.  The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide.

Authors:  Michel Gilbert; Marie-France Karwaski; Stéphane Bernatchez; N Martin Young; Eduardo Taboada; Joseph Michniewicz; Anna-Maria Cunningham; Warren W Wakarchuk
Journal:  J Biol Chem       Date:  2001-10-31       Impact factor: 5.157

4.  Whole genome comparison of Campylobacter jejuni human isolates using a low-cost microarray reveals extensive genetic diversity.

Authors:  N Dorrell; J A Mangan; K G Laing; J Hinds; D Linton; H Al-Ghusein; B G Barrell; J Parkhill; N G Stoker; A V Karlyshev; P D Butcher; B W Wren
Journal:  Genome Res       Date:  2001-10       Impact factor: 9.043

Review 5.  The Campylobacter jejuni glycome.

Authors:  Andrey V Karlyshev; Julian M Ketley; Brendan W Wren
Journal:  FEMS Microbiol Rev       Date:  2005-04       Impact factor: 16.408

6.  Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro.

Authors:  Patricia Guerry; Christine M Szymanski; Martina M Prendergast; Thomas E Hickey; Cheryl P Ewing; Dawn L Pattarini; Anthony P Moran
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

7.  Multiple N-acetyl neuraminic acid synthetase (neuB) genes in Campylobacter jejuni: identification and characterization of the gene involved in sialylation of lipo-oligosaccharide.

Authors:  D Linton; A V Karlyshev; P G Hitchen; H R Morris; A Dell; N A Gregson; B W Wren
Journal:  Mol Microbiol       Date:  2000-03       Impact factor: 3.501

8.  Use of an open-reading frame-specific Campylobacter jejuni DNA microarray as a new genotyping tool for studying epidemiologically related isolates.

Authors:  Edward E Leonard; Tohru Takata; Martin J Blaser; Stanley Falkow; Lucy S Tompkins; Erin C Gaynor
Journal:  J Infect Dis       Date:  2003-01-29       Impact factor: 5.226

9.  Evidence for acquisition of the lipooligosaccharide biosynthesis locus in Campylobacter jejuni GB11, a strain isolated from a patient with Guillain-Barré syndrome, by horizontal exchange.

Authors:  Michel Gilbert; Peggy C R Godschalk; Marie-France Karwaski; C Wim Ang; Alex van Belkum; Jianjun Li; Warren W Wakarchuk; Hubert P Endtz
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

10.  Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients.

Authors:  C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

View more
  48 in total

1.  Comparative characterization of the virulence gene clusters (lipooligosaccharide [LOS] and capsular polysaccharide [CPS]) for Campylobacter coli, Campylobacter jejuni subsp. jejuni and related Campylobacter species.

Authors:  Vincent P Richards; Tristan Lefébure; Paulina D Pavinski Bitar; Michael J Stanhope
Journal:  Infect Genet Evol       Date:  2012-12-29       Impact factor: 3.342

2.  GQ1b-seronegative Fisher syndrome: clinical features and new serological markers.

Authors:  Michiaki Koga; Michel Gilbert; Masaki Takahashi; Jianjun Li; Koichi Hirata; Takashi Kanda; Nobuhiro Yuki
Journal:  J Neurol       Date:  2012-01-05       Impact factor: 4.849

3.  Characterization of the dTDP-Fuc3N and dTDP-Qui3N biosynthetic pathways in Campylobacter jejuni 81116.

Authors:  Zack Z Li; Alexander S Riegert; Marie-France Goneau; Anna M Cunningham; Evgeny Vinogradov; Jianjun Li; Ian C Schoenhofen; James B Thoden; Hazel M Holden; Michel Gilbert
Journal:  Glycobiology       Date:  2017-04-01       Impact factor: 4.313

4.  Characterization of the specific interaction between sialoadhesin and sialylated Campylobacter jejuni lipooligosaccharides.

Authors:  Astrid P Heikema; Mathijs P Bergman; Hannah Richards; Paul R Crocker; Michel Gilbert; Janneke N Samsom; Willem J B van Wamel; Hubert P Endtz; Alex van Belkum
Journal:  Infect Immun       Date:  2010-04-26       Impact factor: 3.441

Review 5.  The sweet tooth of bacteria: common themes in bacterial glycoconjugates.

Authors:  Hanne L P Tytgat; Sarah Lebeer
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

6.  Lipooligosaccharide locus classes are associated with certain Campylobacter jejuni multilocus sequence types.

Authors:  J Revez; M-L Hanninen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09       Impact factor: 3.267

7.  Is the Campylobacter jejuni secretory protein Cj0069 a suitable antigen for serodiagnostics?

Authors:  J Corso; R Lugert; U Groß; A E Zautner
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-03

8.  Characteristics of lipo-oligosaccharide loci of Campylobacter jejuni isolates associated with Guillain-Barré Syndrome from Hebei, China.

Authors:  Hai Jiang; Mao-Jun Zhang; Rui-Chun Liu; Xin-Ying Tian; Yi-Xin Gu; Jian-Zhong Zhang
Journal:  Int J Mol Sci       Date:  2010-03-19       Impact factor: 5.923

9.  Genomic characterization of the Guillain-Barre syndrome-associated Campylobacter jejuni ICDCCJ07001 Isolate.

Authors:  Maojun Zhang; Lihua He; Qun Li; Honghe Sun; Yixin Gu; Yuanhai You; Fanliang Meng; Jianzhong Zhang
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

10.  Comparative genotyping of Campylobacter jejuni strains from patients with Guillain-Barré syndrome in Bangladesh.

Authors:  Zhahirul Islam; Alex van Belkum; Jaap A Wagenaar; Alison J Cody; Albert G de Boer; Helen Tabor; Bart C Jacobs; Kaisar A Talukder; Hubert P Endtz
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.